biOasis/UCB sign research pact

biOasis Technologies has entered into a research collaboration agreement with UCB, to evaluate biOasis' Transcend technology in the delivery of therapeutic compounds to the brain. In connection with this agreement, biOasis will conduct certain experiments to provide UCB with confirmation of the Transcend technology as it relates to the delivery of therapeutic compounds owned by UCB, to the CNS. Financial terms of the agreement were not disclosed.

This article is tagged to:
Sector: Medical Devices
Geography: Belgium, Canada

Access all of our latest analysis, data and forecasts - request a trial